Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06261840 · ClinicalTrials.gov registry record · Phase 4
Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole
A Phase 4 study of Trichomonas Vaginitis and Bacterial Vaginitis, sponsored by Tulane University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 1,200
- Enrollment target
- 4
- Study locations
NCT06261840 is a Phase 4 study of Trichomonas Vaginitis and Bacterial Vaginitis that is actively recruiting participants, run by Tulane University. The registered enrollment target is 1,200 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT06261840, a Phase 4 study of Trichomonas Vaginitis and Bacterial Vaginitis, is actively recruiting participants, sponsored by Tulane University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 1,200 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a multi-centered, randomized, open-label, parallel, phase IV clinical trial comparing the effectiveness and cost-effectiveness of oral multi-dose metronidazole (MTZ) and oral single-dose secnidazole (SEC) for the treatment of Trichomonas vaginalis in both women and men.
Conditions Studied
Interventions
- DRUG Metronidazole 500 mg
- DRUG Secnidazole 2000 MG
Study Locations (4)
Alabama
- University of Alabama at Birmingham [UAB] Gynecology Clinics - Birmingham
- UAB Sexual Health Research Clinic [SHRC] - Birmingham
Florida
- Segal Trials Healthcare Clinical Data, Inc. 1065 NE 125th St. Suite 417 North Miami, FL 33161 - North Miami
Louisiana
- LSU-CrescentCare Sexual Health Center - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2025-05-06 |
| Est. Completion | 2029-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06261840
The ClinicalTrials.gov registry entry for NCT06261840 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Trichomonas Vaginitis appearing as the primary indexed condition, and to 2 interventions - of which Metronidazole 500 mg is the first listed.
NCT06261840 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Alabama, Florida, Louisiana.
Frequently Asked Questions
What is clinical trial NCT06261840 about?
NCT06261840 is a clinical study titled "Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole". This is a multi-centered, randomized, open-label, parallel, phase IV clinical trial comparing the effectiveness and cost-effectiveness of oral multi-dose metronidazole (MTZ) and oral single-dose secnidazole (SEC) for the treatment of Trichomonas vaginalis in both women and men.
What is the current status of trial NCT06261840?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 1,200 participants. The study started on 2025-05-06. Estimated completion is 2029-07-31.
What conditions does trial NCT06261840 study?
This clinical trial studies the following conditions: Trichomonas Vaginitis, Bacterial Vaginitis.
What interventions are being tested in trial NCT06261840?
The interventions under investigation include: Metronidazole 500 mg (DRUG), Secnidazole 2000 MG (DRUG).
Who is sponsoring clinical trial NCT06261840?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06261840 being conducted?
This trial has 4 study locations across Alabama, Florida, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trichomonas Vaginitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.